EUCTR2012-004163-50-ES
Active, Not Recruiting
N/A
Comparative, randomized, double-blind clinical trial on end-tidal concentration of sevoflurane associated to remifentanil required for insertion of the SupremeLaryngeal Mask vs. Pro-Seal Laryngeal Mask
ConditionsPatients requiring general anesthesia in whom the control of the airwayis usually done with a supraglottic device.MedDRA version: 16.1Level: LLTClassification code 10018061Term: General anesthesiaSystem Organ Class: 100000004865Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
DrugsSevorane
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Patients requiring general anesthesia in whom the control of the airwayis usually done with a supraglottic device.
- Sponsor
- Fundación para la Investigación Biomédica del Hospital
- Status
- Active, Not Recruiting
- Last Updated
- 10 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •ASA I and II patients,
- •aged 18\-75 years,
- •they are to be conducted outpatient surgery using laryngeal mask: minor procedures vascular surgery, abdominal, plastic, urological and minor orthopedic surgery
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 50
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •?background of of difficult airway
- •? difficult airway parameters, combining Mallamapati III or IV, thyromental distance \<6 cm and decreased mouth opening \< than 3 cm.
- •? Risk factors of aspiration of gastric contents: hiatal hernia symptoms frequent (daily or weekly)
- •? History of recent respiratory infection.
- •? Pregnancy and breastfeeding.
- •? Patient refusal to participate in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
clinical trial or the anti-inflammatory effects of Curazink for 8 weeks in elderly patients with mild cognitive impairment in Alzheimer's disease or in patients with mild Alzheimer's diseaseIncluded are patients with the presence of a moderate or pronounced zinc deficienc and the diagnosis of a mild cognitive disorder, which may be due to an additional investigation (amyloid PET and / or cerebrospinal fluid) in the context of already performed diagnostic clarification an Alzheimer's pathology.Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2018-000342-19-DEOtto-von-Guericke-Universität Magdeburg, Medizinische Fakultät40
Active, Not Recruiting
Phase 1
Double-blind, randomized, controlled, clinical trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19COVID-related Acute Respiratory Distress SyndromeMedDRA version: 21.1Level: PTClassification code 10001052Term: Acute respiratory distress syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2020-002193-27-ESCristina Avendano-Sola20
Not Yet Recruiting
N/A
Comparative clinical trial to evaluate the performance of implant crowns manufactured using multilayer zirconia materials of domestic and foreign productsKCT0009573Yonsei University Health System, Dental Hospital26
Not Yet Recruiting
Phase 2
Ayurvedic intervention in severe grade Pre menstrual syndromeCTRI/2024/04/066481Shri Dhanwantry Ayurvedic College and Hospital Sector 46 B Chandigarh
Not Yet Recruiting
Phase 2
Clinical Trial of Herbal Preparation (Laxoherb Kid SyrupR) for Constipation in ChildreHealth Condition 1: K929- Disease of digestive system, unspecifiedCTRI/2024/08/072577Jupiter Pharmaceuticals Limited